T A KELLY - JoVE Visualize

Showing results (21-30 of 29) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 29 results.

The American Journal of Cardiology|September 15, 1994

Benefit of late coronary reperfusion in patients with acute myocardial infarction and persistent ischemic chest painB R Brodie, T D Stuckey, C Hansen, et al.

Journal of Medicinal Chemistry|November 24, 1995

Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapineT A Kelly, J R Proudfoot, D W McNeil, et al.

Journal of Medicinal Chemistry|November 24, 1995

Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. 4. 2-Substituted dipyridodiazepinones as potent inhibitors of both wild-type and cysteine-181 HIV-1 reverse transcriptase enzymesJ R Proudfoot, K D Hargrave, S R Kapadia, et al.

The American Journal of Cardiology|July 22, 1998

Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor BlockadeS Ghaffari, D J Kereiakes, A M Lincoff, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999

Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesionT A Kelly, D D Jeanfavre, D W McNeil, et al.

Journal of Medicinal Chemistry|May 10, 1996

Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptidesS J Coutts, T A Kelly, R J Snow, et al.

Journal of the American Chemical Society|June 14, 2001

Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein--protein interactionK Last-Barney, W Davidson, M Cardozo, et al.

Circulation|April 20, 1999

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, J E Tcheng, R M Califf, et al.

Journal of Medicinal Chemistry|March 14, 1997

Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivityE S Lazer, C K Miao, C L Cywin, et al.

Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 29 results.

The American Journal of Cardiology|September 15, 1994

Benefit of late coronary reperfusion in patients with acute myocardial infarction and persistent ischemic chest painB R Brodie, T D Stuckey, C Hansen, et al.

Journal of Medicinal Chemistry|November 24, 1995

Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapineT A Kelly, J R Proudfoot, D W McNeil, et al.

Journal of Medicinal Chemistry|November 24, 1995

Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. 4. 2-Substituted dipyridodiazepinones as potent inhibitors of both wild-type and cysteine-181 HIV-1 reverse transcriptase enzymesJ R Proudfoot, K D Hargrave, S R Kapadia, et al.

The American Journal of Cardiology|July 22, 1998

Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor BlockadeS Ghaffari, D J Kereiakes, A M Lincoff, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999

Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesionT A Kelly, D D Jeanfavre, D W McNeil, et al.

Journal of Medicinal Chemistry|May 10, 1996

Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptidesS J Coutts, T A Kelly, R J Snow, et al.

Journal of the American Chemical Society|June 14, 2001

Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein--protein interactionK Last-Barney, W Davidson, M Cardozo, et al.

Circulation|April 20, 1999

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, J E Tcheng, R M Califf, et al.

Journal of Medicinal Chemistry|March 14, 1997

Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivityE S Lazer, C K Miao, C L Cywin, et al.

Pageof 3